Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness
We are moving from "weight loss drugs" to "metabolic health stabilisers." How sustainable are the results when patients remain on treatments, and when they cease treatment
The Pharmacologic Approaches to Glycemic Management section contains changes that align it with the ADA and the European Association for the Study of Diabetes (EASD) consensus statement published in 2022 and featured in a previous Diabetes Pharmacy Newsletter
J Pers Med 14(7):776 Schaffner M, Mhlberger N, Conrads-Frank A, Qerimi Rushaj V, Sroczynski G, Koukkou E, Heinsbaek Thuesen B, Vlzke H, Oberaigner W, Siebert U (2021) Benefits and harms of a prevention program for iodine deficiency disorders: predictions of the decision-analytic euthyroid model
The first studies with BPC 157 focused on its prominent beneficial effects on gastric and intestinal injuries induced by diverse ulcerogens (18)